Lauris Olivier

Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.

Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France.

Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada.

BIObank SA engages in human tissue development. It prepares, preserves, distributes, and transfers tissues for therapeutic human use. The company was founded by Philippe Chaix, Pierre Lory, and William Gazi on November 4, 1999 and is headquartered in Lieusaint, France.

Solem SAS manufactures hardware materials. It specializes in hoisting and handling equipment. The company was founded on July 21, 1987 and is headquartered in Epinay-sur-Seine, France.

Web Printing International SAS provides image and document printing services. It offers flyers, brochures, invitations, calling card, and prints for t-shirts. The company was founded by Rafik Dany Smati and Vincent Huguet in 2007 and is headquartered in Puteaux, France.

Turenne Holding provides business and management advisory services. The private company is based in Paris, France.

Rfas 4 functions as an investment holding French company. The private company is based in Paris, France. and has subsidiaries in France.